Recent legislation impacts development of biologics
1min
Ha Kung Wong and Vishal Gupta’s article, “Recent legislation impacts development of biologics,” was featured in the November issue of Financier Worldwide.
Samsung Bioepis and Formycon’s EYLEA® IPRs Discretionarily Denied Institution Among Wave of Fintiv Denials; Regeneron Files Second BPCIA Lawsuit Against Amgen’s Pavblu™